Schematic overview of participant sampling timeline.

<p>(A) Individuals with a confirmed HIV-1 diagnosis started treatment during acute infection and were followed up in time. Blood sampling was performed at undetectable (UD; n = 9)) viral load (< 20 copies/mL) and again after 5 subsequent years (UD + 5; n = 5). (B) Individuals with a confirm...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Tine Struyve (22683295) (author)
Άλλοι συγγραφείς:	Marion Pardons (6407921) (author), Jozefien De Clercq (17737815) (author), Liesbet Termote (22683298) (author), Laurens Lambrechts (10532207) (author), Ytse Noppe (22683301) (author), Mathias Lichterfeld (57148) (author), Sofie Rutsaert (10667718) (author), Linos Vandekerckhove (105574) (author)
Έκδοση:	2025
Θέματα:	Biochemistry Medicine Neuroscience Biotechnology Evolutionary Biology Ecology Cancer Infectious Diseases Plant Biology Virology Computational Biology phorbol myristate acetate integration selection mechanisms xlink "> persistence small reservoir sizes treatment initiation timing clonal expansion contributes art ), irrespective individuals treated shortly reservoir persistence early reservoir persistence clonal expansion started treatment pma ), art initiation viral reservoir treated individuals inducible reservoir individuals treated 1 reservoir suggesting post proviruses integrated progressively enriched one year major barrier longitudinal analysis heterochromatin regions five years chronic cohorts cell compartment antiretroviral therapy already detected
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Schematic overview of participant sampling timeline.

Παρόμοια τεκμήρια